Evaluation of biomarkers to differentiate upper from lower urinary tract infections in children

UroToday International Journal

Volumn 4, Issue 4, 2011, Pages

  Al Sayyad, Ahmed J ^a   El Morshedy, Salah M ^a   Abd Al Hamid, Ehab A ^a   Karam, Nehad A ^b   Imam, Basset A A ^a   Karam, Rehab A ^c  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b ZAGAZIG UNIVERSITY   (Egypt)

^c Zagazig University   (Egypt)

Author keywords

Acute pyelonephritis; Biomarkers; Urinary tract infection

Indexed keywords

EID: 84055183455     PISSN: None     EISSN: 19394810     Source Type: Journal    
DOI: 10.3834/uij.1944-5784.2011.08.05     Document Type: Article

References (29)

1. Craig JC, Wheeler DM, Irwig L, Howman-Giles RB. How accurate is dimercaptosuccinic acid scintigraphy for the diagnosis of acute pyelonephritis? A meta-analysis of experimental studies. J Nucl Med. 2000;41(6):986-993.
2. Robles Garcia B, Rodríguez Fernandez LM, Suárez Rodriguez MA, Marugan de Miguelsanz JM, Fernández M, Fuentes MC. Comparison of the usefulness of fever and some laboratory tests for the diagnosis of acute pyelonephritis in children [article in Spanish]. Rev Esp Pediatr. 2005;61:358-363.
3. Ataei N, Madani A, Habibi R, Khorasani M. Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years. Pediatr Nephrol. 2005;20(10):1439-1444.
4. Shah G, Upadhyay J. Controversies in the diagnosis and management of urinary tract infections in children. Paediatr Drugs. 2005;7(6):339-346.
5. Godaly G, Otto G, Burdick MD, Strieter RM, Svanborg C. Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int. 2007;71(8):778-786.
6. Gürgöze MK, Akarsu S, Yilmaz E, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol. 2005;20(10):1445-1448.
7. Rodríguez LM, Marugán JM, Suárez MA, Torres MC. Cytokines in pediatric nephrourologic pathology [article in Spanish]. Arch Latinoam Nefrol Ped. 2003;3(2):73-81.
8. Gervaix A, Galetto-Lacour A, Gueron T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J. 2001;20(5):507-511.
9. Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum. 2003;48(2):291-299.
10. Metz CN, Bucala R. Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv Immunol. 1997;66:197-223.
11. Metz CN, Bucala R. MIF. In: Oppenheim JJ, Feldman M, eds. Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense. Vol 1. San Diego, CA: Academic Press; 2001:703-716.
12. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin--a new indicator of the systemic response to severe infections. Infection. 1997;25(6):329-334.
13. Espinosa L. Infección urinaria. In: Garcia Nieto V, Santos F, Rodri ́guez Iturbe B, eds. Nefrología Pediátrica. 2nd ed. Madrid: Aula Médica; 2006:507-520.
14. Harbert JC, Eckelman WC, Neumann RD. Nuclear Medicine, Diagnosis and Therapy. 1st ed. New York, NY:Thieme Medical; 1996:713-743.
15. Patel K, Charron M, Hoberman A, Brown ML, Rogers KD. Intra- and interobserver variability in interpretation of DMSA scans using a set of standardized criteria. Pediatr Radiol. 1993;23(7):506-509.
16. Lin KY, Chiu NT, Chen MJ, et al. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol. 2003;18(4):362-365.
17. Kotoula A, Gardikis S, Tsalkidis A, et al. Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI: preliminary results. Int Urol Nephrol. 2009;41(2):393-399.
18. Benador N, Siegrist CA, Gendrel D, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics. 1998;102(6):1422-1425.
19. Gervaix A, Galetto-Lacour A, Gueron T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J. 2001;20(5):507-511.
20. Tuerlinckx D, Vander Borght T, Glupczynski Y, et al. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr. 2005;164(10):651-652.
21. Güven AG, Kazdal HZ, Koyun M, et al. Accurate diagnosis of acute pyelonephritis: How helpful is procalcitonin? Nucl Med Commun. 2006;27(9):715-721.
22. Marugán Miguelsanz JM, Suárez Rodriguez MA, Rodríguez Fernandez LM, García Ruiz De Morales JM. Normal levels of interleukin 6 and 8 in serum and urine of healthy asymptomatic children [article in Spanish]. Bol Pediatr. 2005;45:177-184.
23. Sheu JN, Chen MC, Lue KH, et al. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006;36(5-6):276-282.
24. Rodríguez LM, Robles B, Marugán JM, Suárez A, Santos F. Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections. Pediatr Nephrol. 2008;23(3):429-433.
25. Gürgöze MK, Akarsu S, Yilmaz E, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol. 2005;20(10):1445-1448.
26. Huang XR, Chun Hui CW, Chen YX, et al. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology. 2001;121(3):619-630.
27. Ohkawara T, Nishihira J, Takeda H, et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology. 2002;123(1):256-270.
28. Otukesh H, Fereshtehnejad SM, Hoseini R, et al. Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis. Pediatr Nephrol. 2009;24(1):105-111.
29. Sevketoglu E, Yilmaz A, Gedikbasi A, et al. Urinary macrophage migration inhibitory factor in children with urinary tract infection. Pediatr Nephrol. 2010;25(2):299-304.